Clinical and Ultrasonographic Remission in Bio-naïve and Bio-failure Patients with Rheumatoid Arthritis at 24 Weeks of Upadacitinib Treatment: The UPARAREMUS Real-Life Study
Andrea Picchianti Diamanti(Sapienza University of Rome), Annamaria Iagnocco(University of Turin), Bruno Frediani, Roberta Rosa(University of Naples Federico II), Maria Sofia Cattaruzza(Sapienza University of Rome), Gian Domenico Sebastiani(Carlo Forlanini Hospital), Maria Sole Chimenti(University of Rome Tor Vergata), Marco Canzoni(Azienda Sanitaria Locale Viterbo), Chiara De Lorenzo(Sapienza University of Rome), Ivan Giovannini(University of Udine), Valentino Paci(Marche Polytechnic University), Chiara Scirocco, Alen Zabotti(University of Udine), Michele Maria Luchetti(Ospedali Riuniti Umberto I), Bruno Laganà, Arianna D’Antonio(University of Rome Tor Vergata), Giorgio Sesti(Sapienza University of Rome), Carlo Perricone(Sapienza University of Rome), Gloria Maria Felice(Sapienza University of Rome), Simonetta Salemi(Sapienza University of Rome), G. Crepaldi(University of Turin), Caterina Baldi(University of Siena)
Cited by 11
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
2022 update
|Radboud Repository (Radboud University)|2010|1.6k
A chart of failure risk for noninvasive ventilation in patients with COPD exacerbation
|European Respiratory Journal|2005|383
Diabetes Is an Independent Predictor for Severe Osteoarthritis
|Diabetes Care|2012|334